Forest Laboratories

Pharma

AbbVie inks $54M deal to resolve Namenda pay-for-delay suit

A protracted legal fight over an alleged "pay-for-delay" deal on AbbVie's Alzheimer's disease drug Namenda may be nearing its end.
Zoey Becker Nov 15, 2022 11:09am

Judge opts for jury trial in Alzheimer's drug case

Jun 14, 2021 11:19am

Allergan swaps director position after investors demand change

Jun 14, 2018 11:45am

One more time: We're not buying Valeant, Allergan CEO insists

Feb 23, 2017 8:59am

Allergan CEO adds chairman job as journey to brands wraps up

Oct 27, 2016 9:08am

Pfizer leads busy bond week; GSK gets green light for U.K. expansion;

May 19, 2014 11:37am